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ABSTRACT A powerful and potentially general approach
to the targeting and crystallization of proteins on lipid
interfaces through coordination of surface histidine residues
to lipid-chelated divalent metal ions is presented. This ap-
proach, which should be applicable to the crystallization of a
wide range of naturally occurring or engineered proteins, is
illustrated here by the crystallization of streptavidin on a
monolayer of an iminodiacetate-Cu(II) lipid spread at the
air-water interface. This method allows control of the protein
orientation at interfaces, which is significant for the facile
production of highly ordered protein arrays and for electron
density mapping in structural analysis of two-dimensional
crystals. Binding of native streptavidin to the iminodiac-
etate-Cu lipids occurs via His-87, located on the protein
surface near the biotin binding pocket. The two-dimensional
streptavidin crystals show a previously undescribed micro-
scopic shape that differs from that of crystals formed beneath
biotinylated lipids.
The two-dimensional (2D) crystallization of proteins on lipid
monolayers has become a powerful technique with diverse
applications in fields ranging from structural biology to ma-
terials science. Protein 2D crystals have been used for struc-
ture determination via electron diffraction (1, 2) and for the
seeding and epitaxial growth of three-dimensional protein
crystals (3, 4). Furthermore, 2D protein crystals could form
the basic structure of biosensors and opto-electronic devices or
act as a template for the synthesis of novel organic and
inorganic materials. However, the range of soluble proteins
that might be crystallized in two dimensions has been limited
due to the lack of a general method for addressing proteins to
lipid interfaces.
A number of proteins have been crystallized at interfaces by
targeting to surface-bound affinity ligands (1, 5), by electro-
static interactions (6), and by metal coordination by polyhis-
tidine-tagged proteins (7). The first approach requires synthe-
sis of a lipid displaying an appropriate affinity ligand (8-10).
Furthermore, for many interesting proteins no convenient
affinity ligand is known. Electrostatic.attraction may be suc-
cessful when the protein's surface charge distribution pro-
motes adsorption with a unique orientation at the interface,
but this approach is not general, and the protein orientation is
difficult to predict. Kubalek et al. (10) recently described the
2D crystallization of polyhistidine-tagged HIV-reverse tran-
scriptase on a monolayer of chelating lipids complexed to Ni2+.
Polyhistidine fusion peptides, widely used for purification of
recombinant proteins by immobilized metal-affinity chroma-
tography (IMAC) (11), provide a convenient mechanism for
targeting recombinant proteins to lipid interfaces (12, 13).
While this approach represents a valuable move toward more
general crystallization methods, the peptide tag at the N or C
terminus of the engineered protein imposes restrictions on the
2D crystal morphology and limits application to recombinant
proteins successfully expressed with the polyhistidine sequence. A
general method by which water-soluble proteins can be targeted,
oriented, and crystallized at interfaces is highly desirable.
In contrast to the binding interactions described above,
coordination to Cu2+-chelating lipids by naturally occurring
solvent-exposed histidine residues offers a potentially general
approach to the crystallization of proteins at the air-water
interface. This approach can be exploited with the very large
number of native proteins that display histidines on their
surfaces. Furthermore, the ability to engineer histidine resi-
dues at precise locations on the protein surface wcfuld allow
control over protein orientation and 2D crystal morphology,
useful for the structural analysis of 2D crystals as well as for
applications in materials science and design of molecular devices.
We show here that naturally occurring surface histidines can
be utilized to bind and crystallize the protein streptavidin on
a monolayer of iminodiacetate-Cu2+ (IDA-Cu) lipids. Metal-
affinity chromatography on an IDA-Cu column shows that
protein interaction with IDA-Cu at neutral pH is generally
limited to metal coordination by surface-accessible histidine
residues (Ka 1035 M-' for imidazole or a single surface
histidine); at higher pH additional basic groups (lysine, N
terminus) can also participate (14). We have previously shown
by ESR and diethylpyrocarbonate modification that native
proteins are targeted to IDA-Cu lipid assemblies through
coordination by surface histidines (15).
Streptavidin is a tetrameric protein (Mr = 60,000) that binds
the small molecule biotin, also known as vitamin H, with high
affinity (Ka 1015 M-1). The three-dimensional structure of
streptavidin has been well characterized (16-19), and the
protein is known to crystallize two dimensionally beneath
monolayers of biotinylated lipids (20). 2D crystallization of
streptavidin has also been induced by electrostatic interactions
with a monolayer of poly(1-benzyl-L-histidine) (6). Streptavi-
din contains two surface-accessible histidine residues per
subunit at positions 87 and 127 (18, 19), which, combined with the
available structural information, make streptavidin an attractive
model system for investigating this 2D crystallization approach.
MATERIALS AND METHODS
Streptavidin Mutants. The H87A and H127C streptavidin
mutants were created by site-directed cassette mutagenesis of
a synthetic "core" streptavidin gene encoding residues 13-139
of native streptavidin (21). Oligodeoxyribonucleotides span-
ning the MluI-HindIII and BspEI-MscI restriction sites were
Abbreviations: 2D, two dimensional; IDA, iminodiacetate; IMAC,
immobilized metal-affinity chromatography; BAM, Brewster angle
microscope; DOIDA, 1,2-dioleyl-rac-glycero-3-(8-(3,6-dioxy)octyl-1-
amino-N,N-diacetic acid).
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used for the H127C (22) and H87A mutations, respectively.
The mutant sequences were confirmed with automated DNA
sequencing and subsequently subcloned into pET-21a (Nova-
gen) for expression in Escherichia coli BL21(DE3). Procedures
used for expression, refolding, and purification of the mutants
are those described previously for recombinant wild-type
streptavidin (21).
Langmuir Trough and Solutions. The experiments were
performed at room temperature in a Langmuir trough 5-6 mm
deep and equipped with two movable barriers. The surface
pressure and the movement of the barriers are computer
controlled. The subphase for all experiments contained a
buffer of 20 mM Mops and 250 mM NaCl (all from Sigma) at
pH 7.8. The buffer was shaken with chloroform to remove
organic contamination. After the phases had separated, the
aqueous part was shaken with hexane to extract traces of
chloroform. Core streptavidin (Boehringer Mannheim) was
dissolved in the buffer described above. The protein concen-
tration was determined by absorption spectroscopy at 280 nm
with an absorption coefficient for the protein of 136,000
M'- cm-l. The monolayer experiments were performed under
argon atmosphere to prevent oxidation of the unsaturated
alkyl chains. After spreading, the lipid was compressed to a
surface pressure of 3 mN/m, and the protein solution was
injected between the barriers through the surface into the
subphase with a micropipettor. The final protein concentration
in the trough was about 8 jig/ml (- 150 nM). Injection of either
EDTA (Aldrich) or biotin (Boehringer Mannheim) was per-
formed with a micropipettor behind the barriers.
Brewster Angle Microscopy. The home-built Brewster angle
microscope (BAM) is mounted above the Langmuir trough
(see Fig. 2). The incoming He-Ne laser light of 10 mW is
p-polarized by a Glan-Thompson polarizer (intensity ratio,
10-5) at an angle of incidence of 53.120 with respect to the
surface normal (Brewster angle for the air-water interface).
The intensity reflected from the plain air-water interface at
the Brewster angle is at the detection limit. The light reflected
under p-polarization is collected by a lens system to form an
image on a charge-coupled device camera. Because the BAM
signal intensity is highly dependent on the water level, this was
maintained automatically at a constant height by a home-built
level control. The absolute intensity of reflected p-polarized
light was stable and reproducible from experiment to exper-
iment to within 1%.
Metal-Affinity Chromatography. The IMAC column (TSK
Chelate-G6000XL, 7.5 cm x 7.5 mm; TosoHaas, Montgom-
eryville, PA) was regenerated and loaded with Cu2+ (23) and
subsequently equilibrated with 10 ml of 50 mM sodium phos-
phate/0.5 M NaCl/100 mM imidazole, pH 7.8, followed by 10
ml of the same buffer containing 1 mM imidazole. Experi-
ments were performed at a flow rate of 1 ml/min. After
injecting protein (150 Al of 20 ,M streptavidin) the column
was washed with 6 ml of buffer containing 1 mM imidazole.
The protein was then eluted with a linear gradient of imidazole
from 1 to 100 mM over 114 ml, and the eluent was monitored
by absorbance at 280 nm. The chromatograms have been
corrected for the changing baseline due to absorbance of
imidazole by subtraction of the trace obtained in the absence
of protein.
RESULTS AND DISCUSSION
The surface active metal chelator DOIDA [1,2-dioleyl-rac-
glycero-3-(8-(3,6-dioxy)octyl-1-amino-N,N-diacetic acid)]
(Fig. 1) was designed especially for 2D protein crystallization.
The IDA headgroup is attached to the glycerol backbone
through a long (-11.5 A) triethylene glycol spacer to allow the
metal-ion complex free access to the subphase. Tridentate
IDA chelates divalent metal ions very tightly [Ka 1011 M-1
for Cu2+ (24)], leaving coordination sites available for ligand
+ EDTA
N
_
H
FIG. 1. Structure of the Cu(II)-chelating lipid DOIDA and its
complex with a surface histidine. Addition of the soluble chelator
EDTA removes Cu(II) and disrupts the ternary lipid-metal ion-
protein complex.
binding, as illustrated in Fig. 1. Furthermore, the hydrophilic
nature of the IDA-metal complex confers necessary am-
phiphilic character without incorporating ionic groups that can
participate in nonspecific electrostatic interactions with pro-
teins. The unsaturated dioleyl tails ensure the stability and
fluidity of DOIDA Langmuir monolayers.
The DOIDA-Cu lipid was synthesized according to the
sequence outlined in Fig. 2. Details of the synthesis will be
presented elsewhere. The DOIDA glycerol backbone connects
two ether-linked oleyl tails at positions 2 and 3 and a hydro-
philic spacer to the chelating IDA headgroup on position 1.
The trityl-protected glycerol 2 (prepared from glycerol 1) and
oleyl mesylate 4 (prepared from oleyl alcohol 3) were coupled
to produce 5. Deprotection of the trityl group and esterifica-
tion with 1-(methylsulfonyl)-9-(triphenylcarbinyl)-3,6,9-
trioxynonane, prepared from triethylene glycol, introduced the
triethylene glycol spacer group to the main lipid body (7).
Subsequent functional group manipulation at the head group
position according to modified procedures by Ng et al. (12)
gave the iminodiacetic acid functionality. The DOIDA lipid
was metalated by addition of a slight molar excess (<10%) of
CuCl2 dissolved in MeOH to the lipid solution in CHCl3.
DOIDA forms stable monolayers at the air-water interface,
both in the presence and absence of metal ions, and remains
in the fluid state over a wide range of surface pressures due to
the unsaturated lipid tails (unpublished results). For crystal-
lization studies, the chelating lipid was loaded with Cu2+
before spreading of the Langmuir monolayer. Surface pres-
sure-area isotherms of the pre-metallated lipid on buffered
subphase in the absence of divalent metal ions were identical
to the unmetalated lipid spread on the same subphase con-
taining 1-10mM CuCl2, indicating that the metal ion is not lost
to the subphase. Preloading of the lipid with metal was required,
as Cu2+ in solution was found to inhibit binding and crystalliza-
tion of the protein even under a biotinylated monolayer.
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FIG. 2. Synthesis of DOIDA-Cu. Step a: trityl chloride 4-dimethylaminopyridine (DMAP), ET3N, tetrahydrofuran (THF), 12 hr. Step b:
methanesulfonyl chloride (MsCI), CH2C12, Et3M, 12 hr. Step c: powered KOH, dimethyl sulfoxide, 80°C, 36 hr. Step d: TsOH, THF/CH30H, room
temperature, 12 hr. Step e: NaH, 1-(methylsulfonyl)-9-(triphenylcarbinyl)-3.6.9-trioxynonane, THF, reflux, 12 hr. Step f: TsOH, THF/CH30H,
room temperature, 12 hr. Step g: CBr4, PPh3, THF, 0°C to room temperature, 12 hr. Step h: diethyliminodiacetate, Et3N, THF, 72 hr. Step i: NaOH,
THF/CH30H/H20, ref lux, 1 hr. Step j: CuCl2, CH30H/CHCl3, 1 hr.
The surface adsorption and crystallization of streptavidin is
visualized by BAM, a recently developed optical microscopy
technique that allows imaging of molecular monolayers under
Brewster's angle (25, 26). A schematic ofBAM is shown in Fig.
3a. The bare water interface produces no reflection of p-
polarized light incident at Brewster's angle. When a covering
layer even as thin as a molecular monolayer is introduced,
p-polarized light is reflected and an image can be created. In
contrast to fluorescence microscopy, photolabeling of the
protein is not necessary because the signal intensity of the
BAM images increases with the layer thickness and the refrac-
tive index of the interfacial film. It was recently demonstrated
(27) that BAM allows the visualization of surface adsorption
and aggregation of proteins and that a quantitative analysis of
the image gray scale can provide a laterally resolved measure
of protein surface density.
A representative BAM image of 2D biotin lipid-bound
streptavidin aggregates at the air-water interface, which are
known from the literature to be crystalline (3, 20), is shown in
Fig. 3b. Bright H-shaped crystals can be seen on a dark
background. A gray scale analysis of this image shows that
protein is bound not only within the crystals but fills the space
between crystals as well. The crystalline protein density is 20%
higher than the noncrystalline density (27).
For crystallization using the metal-chelating lipids, core
streptavidin was injected beneath a DOIDA-Cu monolayer. A
time sequence of BAM images showing the aggregation pro-
cess of streptavidin is shown in Fig. 4. The first aggregates
appeared 15 min after streptavidin was injected to the final
concentration of 150 nM. The aggregates grown beneath a
DOIDA-Cu monolayer appear bright on a dark background. A
gray scale analysis of these images reveals that the protein
density of the phase surrounding the aggregates is negligible.
The aggregates are rectangular in shape and show sharp edges.
The aggregate size increases as more and more protein adsorbs
to the interface, whereas the sharp-edged shape of the aggregates
is preserved over time. The aggregates tend to interlock at comer
positions, again without inducing a change in their shape.
In contrast to the H-shape of the 2D crystals of strepta-
vidin bound to biotinylated monolayers, copper-bound
streptavidin aggregates are rectangular. Our findings that the
streptavidin aggregates which formed upon binding to
,S CCD camera
b
FIG. 3. (a) Schematic of BAM. The bare water interface produces no reflection ofp-polarized light incident at Brewster's angle. When a covering
layer even as thin as a molecular monolayer is introduced,p-polarized light is reflected, and an image can be created. (b) Brewster angle micrograph
of streptavidin crystals beneath a biotinylated lipid monolayer (DPPE-X-biotin; Molecular Probes). The H-shape is typical of streptavidin crystals
grown on biotinylated-lipid monolayers.
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FIG. 4. Time sequence of BAM images of 2D streptavidin aggre-
gation underneath a monolayer of DOIDA-Cu [3 mN/m2 over 20 mM
Mops and 250 mM NaCl (pH 7.8) at room temperature]. Numbers
indicate minutes after protein injection. Note the different shape of the
aggregates with respect to the H-shaped crystals grown on the
biotinylated-lipid monolayer (Fig. 3). The sharp-edged rectangular
shape of the domains strongly suggests 2D protein crystals.
DOIDA-Cu monolayers all show the same rectangular shape
and that the shape is independent of the aggregate size and the
equilibration time, strongly suggest that the aggregates are, in
fact, 2D streptavidin crystals. IDA-Cu-bound streptavidin
appears to crystallize into a 2D polymorph that is distinct from
the biotin-bound form and manifests itself by a rectangular
microscopic crystal shape, suggesting altered protein-protein
contacts. This is consistent with the ability of streptavidin to
crystallize in several polymorphs in two and three dimensions
(4, 18). Crystallographic characterization of the 2D copper-
bound streptavidin crystals is under way.
Injection of the soluble metal chelator EDTA into the
subphase after the streptavidin crystals had formed at the
interface caused the protein crystals to disappear within
minutes. Routinely used to regenerate IDA-Cu IMAC col-
umns, EDTA competes effectively with the IDA headgroup
for copper ions (Fig. 1) and is effective for eluting strongly
bound proteins. That the streptavidin crystals are disrupted by
EDTA indicates that surface binding requires the presence of
copper ions. In fact, no crystals were observed after injection
of the same amount of streptavidin underneath a DOIDA
monolayer that did not contain Cu2 . In the absence of copper,
essentially no protein bound to the interface.
The orientation assumed by streptavidin upon binding to the
monolayer depends on the location of the IDA-Cu binding
site(s) on the protein surface. Each streptavidin monomer has
two histidine residues; His-87 is located close to the biotin
binding pocket while the His-127 residue lies on the long side
of the barrel at the interface between two subunits, as illus-
trated in Fig. 5. Two His-127 residues from adjacent subunits
come into close contact at the subunit interface and lie on the
surface of the protein in a 14-A deep cleft. The different shape
of copper-bound streptavidin aggregates could be explained if
the two adjacent His-127 residues were responsible for binding,
as monolayer attachment via these residues would be expected
to rotate the streptavidin by roughly 900 with respect to binding
via biotin. Metal coordination by His-127, however, seems
unlikely due to the length of the headgroup spacer (11.5 A)
with respect to the depth of this cleft. A streptavidin mutant
in which His-127 is replaced by cysteine (H127C), in fact,
showed the same adsorption and crystallization behavior as
native streptavidin on DOIDA-Cu monolayers. Thus the two
His-87 are left as the most likely sites for interaction with the
FIG. 5. Structure of the streptavidin tetramer (18) showing the
relative locations of the biotin-binding pocket and histidine residues.
Biotin and the His-87 residues are located on the "top" and "bottom"
of the protein, whereas the His-127 residues lie on the "front" and
"back" faces. The image was created using the programs MOLSCRIPr
and RASTER3D (28-30).
copper-chelate complexes. Experiments performed with a
streptavidin mutant in which His-87 is replaced by Ala (H87A)
demonstrate that His-87 is indeed required for streptavidin
binding to metal-chelating lipids and the subsequent crystal
formation. This mutant shows high affinity for biotin. When
injected to a concentration of 250 nM beneath the DOIDA-Cu
monolayer, however, H87A streptavidin showed no evidence
of binding over a period of 3 hr, as confirmed by a gray scale
analysis of the BAM images.
Streptavidin binding to IDA-Cu-derivatized surfaces re-
quires the presence of His-87, but binding occurs only in the
absence of biotin. Mature aggregates grown on the DOIDA-
Cu monolayer desorbed spontaneously when biotin was in-
jected into the subphase to a total concentration of -2.25 ,uM
(15 times molar excess over the streptavidin concentration). In
addition, when streptavidin is pre-bound with biotin before
injection beneath the DOIDA-Cu monolayer, no protein
surface binding is detected. Similar behavior is observed
during chromatography on an IDA-Cu column. Fig. 6 shows
that apolipoprotein-streptavidin binds rather strongly, requir-
ing '40 mM imidazole to displace it. In contrast, streptavidin
fully loaded with biotin shows little, if any, affinity for the
metal-containing support. We can conclude from these ob-
servations that both the disruption of streptavidin crystals
0
00
x1
80
60
v
40 o
CD
20O
0
time (min)
FIG. 6. Chromatogram showing retention of streptavidin in the
presence and absence of biotin in metal-affinity chromatography on a
IDA-Cu-derivatized support. The protein was eluted with a linear
gradient of imidazole (dotted line). In the absence ofbiotin (solid line),
streptavidin is strongly retained on the IDA-Cu column: 40 mM
imidazole is required for elution. Streptavidin that has been preincu-
bated with four equivalents of biotin is retained only slightly (dashed
line), eluting from the column at the start of the imidazole gradient.
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upon addition of biotin and the absence of 2D crystallization of
biotin-bound streptavidin are due to inhibition of binding to the
IDA-Cu monolayer rather than inhibition of crystallization.
The results reported here indicate that His-87 can coordi-
nate to IDA-Cu only in the absence of biotin. Weber et al. (18)
report biotin-induced conformational changes. These could
render His-87 less accessible for formation of the ternary
IDA-Cu protein complex. Alternatively, biotin-induced con-
formational changes, including hydrogen-bonding between
biotin and neighboring residues, could preclude any confor-
mational changes His-87 must undergo for metal binding.
Further experiments are under way to clarify the mechanism
by which biotin interferes with streptavidin binding to the
IDA-Cu lipid monolayer.
2D crystallization of proteins on metal-chelating lipid mono-
layers via histidine-metal coordination extends the powerful
monolayer 2D crystallization technique to virtually any protein
with accessible histidines, either natural or engineered. Intro-
ducing histidines at specified locations on the protein surface
allows control over protein orientation, a major advantage
with respect to using polyhistidine tags. Thus a larger range of
orientations could be sampled for crystallization, and, in the
event that multiple orientations lead to crystallization, 2D
electron density maps could be obtained for different protein
orientations with respect to the surface plane. In addition to
those benefits to structural biology, the ability to form ordered
arrays of proteins will facilitate the production of novel devices
and functional materials.
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